FOCUS ON HCV TREATMENT BASED ON SECONDGENERATION DIRECT-ACTING ANTIVIRAL AGENTS (DAAS-2): COMPARING NATIONAL AND LOCAL PRESCRIBING TRENDS

FOCUS ON HCV TREATMENT BASED ON SECONDGENERATION DIRECT-ACTING ANTIVIRAL AGENTS (DAAS-2): COMPARING NATIONAL AND LOCAL PRESCRIBING TRENDS